| Thrombosis in primary antiphospholipid syndrome. A pivotal role for monocyte tissue factor expression MJ Cuadrado, C López‐Pedrera, MA Khamashta, MT Camps, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1997 | 269 | 1997 |
| Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF‐κB/Rel proteins … C López‐Pedrera, P Buendía, M José Cuadrado, E Siendones, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 243 | 2006 |
| Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα C Castro-Villegas, C Pérez-Sánchez, A Escudero, I Filipescu, M Verdu, ... Arthritis research & therapy 17, 1-15, 2015 | 194 | 2015 |
| CoCl2, a Mimic of Hypoxia, Induces Formation of Polyploid Giant Cells with Stem Characteristics in Colon Cancer LM Lopez-Sánchez, C Jimenez, A Valverde, V Hernandez, J Penarando, ... PloS one 9 (6), e99143, 2014 | 146 | 2014 |
| Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome R Teruel, C Perez‐Sanchez, J Corral, MT Herranz, V Perez‐Andreu, ... Journal of Thrombosis and Haemostasis 9 (10), 1985-1992, 2011 | 121 | 2011 |
| Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targets I Cecchi, IA de la Rosa, E Menegatti, D Roccatello, E Collantes-Estevez, ... Autoimmunity reviews 17 (11), 1138-1149, 2018 | 114 | 2018 |
| Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q10 treatment C Perez-Sanchez, P Ruiz-Limon, MA Aguirre, ML Bertolaccini, ... Blood, The Journal of the American Society of Hematology 119 (24), 5859-5870, 2012 | 109 | 2012 |
| Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation P Ruiz-Limon, R Ortega, IA de la Rosa, M Del Carmen Abalos-Aguilera, ... Translational Research 183, 87-103, 2017 | 101 | 2017 |
| Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome C López-Pedrera, P Ruiz-Limón, MÁ Aguirre, N Barbarroja, ... Annals of the rheumatic diseases 70 (4), 675-682, 2011 | 101 | 2011 |
| Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus … C Perez-Sanchez, N Barbarroja, S Messineo, P Ruiz-Limon, ... Annals of the rheumatic diseases 74 (7), 1441-1449, 2015 | 98 | 2015 |
| Proteomic analysis of acute myeloid leukemia: Identification of potential early biomarkers and therapeutic targets C López‐Pedrera, JM Villalba, E Siendones, N Barbarroja, ... Proteomics 6 (S1), S293-S299, 2006 | 94 | 2006 |
| Oxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approaches C Lopez-Pedrera, N Barbarroja, Y Jimenez-Gomez, E Collantes-Estevez, ... Rheumatology 55 (12), 2096-2108, 2016 | 78 | 2016 |
| Anticyclic citrullinated protein antibodies are implicated in the development of cardiovascular disease in rheumatoid arthritis N Barbarroja, C Pérez-Sanchez, P Ruiz-Limon, C Castro-Villegas, ... Arteriosclerosis, thrombosis, and vascular biology 34 (12), 2706-2716, 2014 | 75 | 2014 |
| Proteomic analysis in monocytes of antiphospholipid syndrome patients: deregulation of proteins related to the development of thrombosis C López‐Pedrera, MJ Cuadrado, V Herández, P Buendïa, MA Aguirre, ... Arthritis & Rheumatism 58 (9), 2835-2844, 2008 | 75 | 2008 |
| Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment P Ruiz-Limon, N Barbarroja, C Perez-Sanchez, MA Aguirre, ... Annals of the rheumatic diseases 74 (7), 1450-1458, 2015 | 74 | 2015 |
| Increased Dihydroceramide/Ceramide Ratio Mediated by Defective Expression of degs1 Impairs Adipocyte Differentiation and Function N Barbarroja, S Rodriguez-Cuenca, H Nygren, A Camargo, A Pirraco, ... Diabetes 64 (4), 1180-1192, 2015 | 71 | 2015 |
| Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients C Perez-Sanchez, P Font-Ugalde, P Ruiz-Limon, C Lopez-Pedrera, ... Human molecular genetics 27 (5), 875-890, 2018 | 69 | 2018 |
| Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions C López-Pedrera, C Pérez-Sánchez, M Ramos-Casals, ... Journal of Immunology Research 2012, 2012 | 67 | 2012 |
| Blast cell-surface and plasma soluble urokinase receptor in acute leukemia patients: relationship to classification and response to therapy S Mustjoki, R Alitalo, RW Stephens, A Vaheri Thrombosis and haemostasis 81 (05), 705-710, 1999 | 66 | 1999 |
| Ubiquinol effects on antiphospholipid syndrome prothrombotic profile: a randomized, placebo-controlled trial C Pérez-Sánchez, MÁ Aguirre, P Ruiz-Limón, MC Ábalos-Aguilera, ... Arteriosclerosis, thrombosis, and vascular biology 37 (10), 1923-1932, 2017 | 65 | 2017 |
Nuria BarbarrojaInvestigadora "Ramon y Cajal", Departamento de Medicina, Universidad de Cordoba (España)Verified email at uco.es
